Answers are grounded in this paper and cite their sources.
The title suggests that neonates, children, and adolescents have increased dose requirements for enoxaparin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Graham et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: